Successful treatment with bortezomib-containing regimen of primary plasma cell leukemia: a case report.

Pan Afr Med J

Department of Medicine, Hematology and Oncology Unit, King Hussein Medical City, Amman, Jordan.

Published: December 2020

Plasma cell leukemia represents the most aggressive form of plasma cell dyscrasia. We report a 67-year old male with no previous medical illnesses presented with anemic symptoms. Blood film revealed 35% circulating plasma cells, bone marrow biopsy showed plasma cells constituting 85%. Diagnosis of primary plasma cell leukemia was completed. Induction chemotherapy with bortezomib, doxorubicin, and dexamethasone was started. After the first cycle, plasma cells in peripheral blood disappeared. The patient had complete remission at evaluation after the third cycle. Re-evaluation after the sixth cycle showed that he maintained remission. As he was non-transplant eligible, he was we kept on maintenance bortezomib. Twenty-four months after the diagnosis, the patient remains in remission.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388633PMC
http://dx.doi.org/10.11604/pamj.2020.36.15.21717DOI Listing

Publication Analysis

Top Keywords

plasma cell
16
cell leukemia
12
plasma cells
12
primary plasma
8
plasma
7
successful treatment
4
treatment bortezomib-containing
4
bortezomib-containing regimen
4
regimen primary
4
cell
4

Similar Publications

Background: Extracellular vesicles (EVs) have procoagulative properties. As EVs are known to accumulate in stored blood products, we compared the EV content and coagulation capacity of leukoreduced cold-stored whole blood (CSWB) with current prehospital and in-hospital component therapies to understand the role of EVs in the haemostatic capacity of ageing CSWB.

Materials And Methods: Blood was obtained from 12 O RhD-positive male donors.

View Article and Find Full Text PDF

Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT Study.

J Surg Oncol

January 2025

Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, and Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Background And Objectives: Identification of colorectal cancer (CRC) patients at high risk of recurrence could be of substantial clinical use. We evaluated the association of ctDNA status, using a tumor-informed assay, with recurrence-free survival (RFS).

Methods: Stage III CRC patients were enrolled between 2016 and 2020.

View Article and Find Full Text PDF

Accumulation of advanced oxidative protein products exacerbate satellite glial cells activation and neuropathic pain.

Mol Med

January 2025

Division of Spine Surgery, Department of Orthopedics, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Ave, Guangzhou, 510515, People's Republic of China.

Background: Neuropathic pain (NP) is a debilitating condition caused by lesion or dysfunction in the somatosensory nervous system. Accumulation of advanced oxidation protein products (AOPPs) is implicated in mechanical hyperalgesia. However, the effects of AOPPs on NP remain unclear.

View Article and Find Full Text PDF

The stability of kinetic-level convection cells (wherein the magnitude of macroscopic and microscopic velocities are of same order) is studied in a two-dimensional Yukawa liquid under the effect of microscopic velocity perturbations. Our numerical experiments demonstrate that for a given system aspect ratio β viz., the ratio of system length [Formula: see text] to its height [Formula: see text] and number of convective rolls initiated [Formula: see text], the fate of the convective cells is decided by [Formula: see text].

View Article and Find Full Text PDF

[Emphasis the early diagnosis and treatment of plasma cell disease-related kidney disease].

Zhonghua Yi Xue Za Zhi

January 2025

Beijing Chao-Yang Hospital, Capital Medical University, Beijing Multiple Myeloma Research Center, Beijing100020,China.

Plasma cell disorders represent a spectrum of complex diseases, ranging from benign conditions to malignancies. The monoclonal immunoglobulins produced in these disorders can result in various renal pathologies, which may present as differing degrees of renal insufficiency. In severe instances, patients may necessitate dialysis or kidney transplantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!